Filtered By:
Management: Profits and Losses
This page shows you your search results in order of relevance. This is page number 4.
Order by Relevance | Date
Total 84 results found since Jan 2013.
How Do Scientists and the Media Magnify Mercury's Menace?
A thoughtful new analysis of the benefits of reducing public exposure to mercury adds to several studies suggesting that whatever it costs to make those cuts, either under the U.S. Mercury and Air Toxics Rule (MATS) or the international Minamata Convention, it's worth doing. But like that entire body of work, this new analysis is based on a controversial assumption about just how much harm mercury does in the first place. It turns out that this widely known and feared environmental bogeyman might not be as serious a danger as this new study suggests, which the environmental and science media are mostly failing to report. T...
Source: Science - The Huffington Post - February 16, 2016 Category: Science Source Type: news
Fatness, Affluence, Adaptation and Hope
Colleagues and I recently submitted a grant application to a large foundation, seeking funds to support the True Health Initiative. The funds, should we be fortunate enough to secure them, will accelerate the development of a global communication campaign to convey the evidence and consensus-based fundamentals of healthy living, and notably, healthy eating. In particular, the grant would support a rigorous evaluation so that we could demonstrate the replacement of widespread confusion and doubts about consensus related to healthful, sustainable eating at baseline, with clarity and understanding by virtue of our efforts. Th...
Source: Healthy Living - The Huffington Post - February 23, 2016 Category: Consumer Health News Source Type: news
Public Health and Citizens, Truly United
There are just two problems with the prevailing conception of "public health" -- the public, and health. Neither means what we think it means. For starters, there is no public. The public is an anonymous mass, a statistical conception, nameless, faceless, unknowable, and unlovable. I have made the case before that laboring under this crippling fiction, the potential good that all things "public health" might do is much forestalled. We talk, for instance, about the genuine potential to eliminate up to 80 percent of the total global burden of chronic disease -- heart disease, cancer, stroke, diabetes, dementia -- but somehow...
Source: Healthy Living - The Huffington Post - March 3, 2016 Category: Consumer Health News Source Type: news
Synergy, Watchman help Boston Scientific swing to Q1 black
Boston Scientific (NYSE:BSX) reaped the rewards of its turnaround push today with a 1st-quarter swing to black ink, raising its outlook for the rest of the year, helped by contributions from its Synergy and Watchman devices.
Investors reacted by sending BSX shares up 6.0% to $20.85 in pre-market trading this morning.
Marlborough, Mass.-based Boston Scientific reported profits of $202.0 million, or 15¢ per share, on sales of $1.96 billion for the 3 months ended March 31, for an 11% top-line gain compared with Q1 2015, when losses were -$1.o million.
Adjusted to exclude 1-time items, earnings per share were 28¢, 4¢ a...
Source: Mass Device - April 27, 2016 Category: Medical Equipment Authors: Brad Perriello Tags: Cardiovascular MassDevice Earnings Roundup Wall Street Beat Boston Scientific Source Type: news
Needs of Internally Displaced Women and Children in Baghdad, Karbala, and Kirkuk, Iraq
Conclusions
The vulnerability of this population is great, and the emotional trauma of multiple displacements, kidnapping and deaths from intentional violence is great. While some aid is reaching families, much more is needed. Though Iraq is a middle income country, reaching the IDPs in central Iraq will take much more in international assistance than is currently being received. Unfortunately, at this time of great need, assistance is being cut back throughout the region because of lack of funding.10 The local civil society organizations which have sprung up in many locations to assist IDPs, offer an avenue for targeting ...
Source: PLOS Currents Disasters - June 10, 2016 Category: Global & Universal Authors: Gilbert Burnham Source Type: research
Taking Risk: Early Results From Teaching Hospitals’ Participation in the Center for Medicare and Medicaid Innovation Bundled Payments for Care Improvement Initiative
The authors describe observations from the 27 teaching hospitals constituting the Association of American Medical Colleges (AAMC) cohort in the Center for Medicare and Medicaid Innovation (CMMI) Bundled Payments for Care Improvement (BPCI) initiative. CMMI introduced BPCI in August 2011 and selected the first set of participants in January 2013. BPCI participants enter into Medicare payment arrangements for episodes of care for which they take financial risk. The first round of participants entered risk agreements on October 1, 2013 and January 1, 2014. In April 2014, CMMI selected additional participants who started takin...
Source: Academic Medicine - June 30, 2016 Category: Universities & Medical Training Tags: Articles Source Type: research
Our Sedentary Lifestyles Cost About 5 Million Lives A Year
By Kate Kelland
LONDON (Reuters) - A study of one million people has found that physical inactivity costs the global economy $67.5 billion a year in healthcare and productivity losses, but an hour a day of exercise could eliminate most of that.
Sedentary lifestyles are linked to increased risks of heart disease, diabetes and cancer, researchers found, but activity - such as brisk walking - could counter the higher likelihood of early death linked with sitting for eight or more hours a day.
Such inactivity is estimated to cause more than 5 million deaths a year - almost as many as smoking, which the World Health Organi...
Source: Science - The Huffington Post - July 28, 2016 Category: Science Source Type: news
InVivo Therapeutics Q2 meets the street, shares stay steady
InVivo Therapeutics (NSDQ:NVIV) shares stayed steady after the company released 2nd quarter earnings that met the street on losses per share.
The Cambridge, Mass.-based company reported losses of $5.2 million, or 16¢ per share, for the 3 months ended June 30, 2016. That amounts to a 50% reduction in losses for InVivo Therapeutics compared with same period in 2015.
After adjusting to exclude 1-time items, losses per share were 18¢, a good tick below what analysts on Wall Street were looking for with expectations set fro losses of 22¢ per share.
“The 2nd quarter was one marked by continued advancements and outreach...
Source: Mass Device - August 5, 2016 Category: Medical Equipment Authors: Fink Densford Tags: Business/Financial News Neurological Spinal InVivo Therapeutics Corp. Source Type: news
MassDevice.com +5 | The top 5 medtech stories for September 14, 2016
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
Get this in your inbox everyday by subscribing to our newsletters.
5. Light-based arrhythmia treatment skips the shocks
Researchers at Johns Hopkins University and Germany’s University of Bonn showed that light can restore a normal heartbeat and replace electric shocks in patients at risk for a...
Source: Mass Device - September 14, 2016 Category: Medical Equipment Authors: MassDevice Tags: News Well Plus 5 Source Type: news
MassDevice.com +5 | The top 5 medtech stories for April 19, 2017
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
Get this in your inbox everyday by subscribing to our newsletters.
5. Intuitive Surgical shares rise on solid Q1 beat
Shares in Intuitive Surgical rose today in after-hours trading after the robotic surgical platform maker posted 1st quarter earnings that beat expectations on the Street.
The Sunn...
Source: Mass Device - April 19, 2017 Category: Medical Equipment Authors: MassDevice Tags: News Well Plus 5 Source Type: news
Prince Philip's Retirement Shocker Isn't All That Shocking
The Duke of Edinburgh plans to retire from his royal duties this autumn, Buckingham Palace announced Thursday morning, ending a night of speculation and worry that the palace was about to share news of far more gravitas.
So yes, at age 95, Prince Philip is retiring. He spent 110 days of the past year attending official royal events, which makes him the fifth-busiest member of the royal family, according to Court Circular listings and as reported by the BBC. And he will continue to support the queen. But as far as making appearances on his own, well, he’s stepping back.
He has no health issues beyond those a...
Source: Healthy Living - The Huffington Post - May 4, 2017 Category: Consumer Health News Source Type: news
Statins Have a Dose-Dependent Effect on Amputation and Survival in Peripheral Artery Disease Patients.
Conclusions -Statins, especially high intensity formulations, are underutilized in PAD patients. This is the first population based study to show that high intensity statin use at time of PAD diagnosis is associated with a significant reduction in limb loss and mortality compared to low-moderate intensity statin users as well as patients treated only with antiplatelet medications but not with statins.
PMID: 29330214 [PubMed - as supplied by publisher]
Source: Circulation - January 12, 2018 Category: Cardiology Authors: Arya S, Khakharia A, Binney ZO, DeMartino RR, Brewster LP, Goodney PP, Wilson PWF Tags: Circulation Source Type: research
Penumbra shares rise on Q4, FY2017 earnings beat
Shares in Penumbra (NYSE:PEN) rose today after the medical device maker met expectations on Wall Street with its fourth quarter and fiscal year 2017 earnings results.
The Alameda, Calif.-based company posted profits of $9.1 million, or 25¢ per share, on sales of $96 million for the 3 months ended December 31, seeing a massive swing from the red on the bottom line while sales grew 31.4% when compared with the same period last year.
Earnings per share were well above the 1¢ loss-per-share consensus on Wall Street, where analysts were expecting to see sales of $96 million, which the company met.
For the full year, Penumbra...
Source: Mass Device - February 28, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News MassDevice Earnings Roundup Wall Street Beat Penumbra Inc. Source Type: news
ReWalk Robotics inks $20m private placement, posts Q4, 2017 earnings
Shares in ReWalk Robotics (NSDQ:RWLK) have risen today after the company announced a $20 million private placement and posted shrinking losses for the quarter and growing sales for the year with its fourth quarter and 2017 earnings.
The company said it inked an investment agreement with Hong Kong-based Timwell Corporation Limited through which the company will receive $20 million in three tranches through the issuance of 16 million shares at a price of $1.25 per share.
The investment will come in three tranches, with $5 million for an initial 4 million shares in the first, $10 million for 8 million shares in the second an...
Source: Mass Device - March 8, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News MassDevice Earnings Roundup Wall Street Beat ReWalk Robotics Source Type: news
